Strategic Molecular Diagnostics Account Executive – NorCal

Abbott; San Francisco (CA); On-site; USD 78,000 - 156,000; Full time

Job summary

Abbott is seeking a Molecular Account Executive to cover the Northern California territory within the Molecular Diagnostic Division. This field sales role focuses on selling full-stack Molecular products to hospitals, IDNs, reference labs, and women's health offices, partnering with cross-functional teams to win new business and expand existing accounts.

You will engage C-suite and clinical leadership, manage long capital equipment sales cycles, travel up to 50-75%, and drive strategic growth

Qualifications

• Bachelor’s degree required.
• 4+ years of relevant sales experience.
• Must reside in the territory; San Francisco/Bay Area preferred.
• Valid Driver’s License and ability to travel 50-75% within the US.
• Proven success in strategic sales, including multi-stakeholder environments.
• Experience selling capital equipment and to senior-level/C-suite executives.

Responsibilities

• Drive market share growth by identifying and cultivating new business opportunities in the territory.
• Manage long, capital sales cycles with strategic foresight and cross-functional collaboration.
• Collaborate with Enterprise Account Manager to secure business in large hospital systems.
• Lead renewal efforts to ensure customer retention and satisfaction for non-enterprise accounts.

Skills

Strategic sales

Stakeholder management

Communication

Education

Bachelor's degree

Tools

Salesforce.com

Microsoft Office

Job description

Abbott is seeking a Molecular Account Executive to cover the Northern California territory within the Molecular Diagnostic Division. This field sales role focuses on selling full-stack Molecular products to hospitals, IDNs, reference labs, and women's health offices, partnering with cross-functional teams to win new business and expand existing accounts.

You will engage C-suite and clinical leadership, manage long capital equipment sales cycles, travel up to 50-75%, and drive strategic growth